Literature DB >> 21852381

MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells.

Sharanjot Saini1, Soichiro Yamamura, Shahana Majid, Varahram Shahryari, Hiroshi Hirata, Yuichiro Tanaka, Rajvir Dahiya.   

Abstract

Cancer pathogenesis is restricted by stresses that compromise cell division and survival. In this study, we identify miR-708, a little studied member of a set of microRNAs that have been implicated in stress control, as an important tumor suppressor in renal cell carcinoma (RCC). miR-708 expression was attenuated widely in human RCC specimens. Restoration of miR-708 expression in RCC cell lines decreased cell growth, clonability, invasion, and migration and elicited a dramatic increase in apoptosis. Moreover, intratumoral delivery of miR-708 was sufficient to trigger in vivo regression of established tumors in murine xenograft models of human RCC. Investigation of the targets of miR-708 identified the inhibitor of apoptosis protein survivin as important. siRNA-mediated knockdown of survivin partially phenocopied miR-708 overexpression suggesting that the proapoptotic role of miR-708 may be mediated primarily through survivin regulation. Additionally, we identified the E-cadherin regulators ZEB2 and BMI1 as likely miR-708 targets. Taken together, our findings define a major tumor suppressive role for miR-708, which may offer an attractive new target for prognostic and therapeutic intervention in RCC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21852381      PMCID: PMC3940359          DOI: 10.1158/0008-5472.CAN-11-0073

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma.

Authors:  Tetsuhiro Chiba; Satoru Miyagi; Atsunori Saraya; Ryutaro Aoki; Atsuyoshi Seki; Yohei Morita; Yutaka Yonemitsu; Osamu Yokosuka; Hideki Taniguchi; Hiromitsu Nakauchi; Atsushi Iwama
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

Review 2.  Survivin, cancer networks and pathway-directed drug discovery.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2008-01       Impact factor: 60.716

3.  Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway.

Authors:  Dmitriy Ovcharenko; Kevin Kelnar; Charles Johnson; Nan Leng; David Brown
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

4.  Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia.

Authors:  D Schotte; J C K Chau; G Sylvester; G Liu; C Chen; V H J van der Velden; M J C Broekhuis; T C J M Peters; R Pieters; M L den Boer
Journal:  Leukemia       Date:  2008-10-16       Impact factor: 11.528

Review 5.  MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death.

Authors:  R Schickel; B Boyerinas; S-M Park; M E Peter
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

6.  Patterns of known and novel small RNAs in human cervical cancer.

Authors:  Weng-Onn Lui; Nader Pourmand; Bruce K Patterson; Andrew Fire
Journal:  Cancer Res       Date:  2007-07-01       Impact factor: 12.701

Review 7.  MicroRNAs: target recognition and regulatory functions.

Authors:  David P Bartel
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

8.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

9.  MicroRNAs and cancer: short RNAs go a long way.

Authors:  Andrea Ventura; Tyler Jacks
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

10.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  53 in total

1.  EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.

Authors:  Tyler P Robin; Anna Smith; Erin McKinsey; Lisa Reaves; Paul Jedlicka; Heide L Ford
Journal:  Mol Cancer Res       Date:  2012-06-20       Impact factor: 5.852

2.  MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer.

Authors:  Liming Xie; Zhiwei Zhang; Zhiqin Tan; Rongfang He; Xi Zeng; Yuanjie Xie; Suyun Li; Guohua Tang; Hailin Tang; Xiusheng He
Journal:  Mol Cell Biochem       Date:  2014-07       Impact factor: 3.396

Review 3.  Microenvironmental regulation of cancer metastasis by miRNAs.

Authors:  Yun Zhang; Pengyuan Yang; Xiao-Fan Wang
Journal:  Trends Cell Biol       Date:  2013-10-11       Impact factor: 20.808

4.  Effects of microRNA-708 on Epithelial-Mesenchymal Transition, Cell Proliferation and Apoptosis in Melanoma Cells by Targeting LEF1 through the Wnt Signaling Pathway.

Authors:  Xiao-Fei Song; Qi-Hua Wang; Ran Huo
Journal:  Pathol Oncol Res       Date:  2017-11-14       Impact factor: 3.201

Review 5.  MicroRNA regulation and therapeutic targeting of survivin in cancer.

Authors:  Jingcao Huang; Hui Lyu; Jianxiang Wang; Bolin Liu
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

6.  IRF7 promotes glioma cell invasion by inhibiting AGO2 expression.

Authors:  Jun-Kyum Kim; Xiong Jin; Seok Won Ham; Seon Yong Lee; Sunyoung Seo; Sung-Chan Kim; Sung-Hak Kim; Hyunggee Kim
Journal:  Tumour Biol       Date:  2015-02-14

7.  miRNA-708 functions as a tumour suppressor in hepatocellular carcinoma by targeting SMAD3.

Authors:  Qi Li; Sheng Li; Yaolu Wu; Feng Gao
Journal:  Oncol Lett       Date:  2017-06-20       Impact factor: 2.967

Review 8.  The regulation and function of microRNAs in kidney diseases.

Authors:  Qingqing Wei; Qing-Sheng Mi; Zheng Dong
Journal:  IUBMB Life       Date:  2013-07       Impact factor: 3.885

9.  Elevated miR-182-5p Associates with Renal Cancer Cell Mitotic Arrest through Diminished MALAT-1 Expression.

Authors:  Priyanka Kulkarni; Pritha Dasgupta; Nadeem S Bhat; Varahram Shahryari; Marisa Shiina; Yutaka Hashimoto; Shahana Majid; Guoren Deng; Sharanjot Saini; Z Laura Tabatabai; Soichiro Yamamura; Yuichiro Tanaka; Rajvir Dahiya
Journal:  Mol Cancer Res       Date:  2018-07-23       Impact factor: 5.852

10.  Tumor suppressive miR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma.

Authors:  W-B Zhang; Z-Q Pan; Q-S Yang; X-M Zheng
Journal:  Ir J Med Sci       Date:  2013-04-26       Impact factor: 1.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.